Global Lung Cancer Diagnostics Market Size, Status and Forecast 2024-2031

Report ID: 954510 | Published Date: Sep 2024 | No. of Page: 105 | Base Year: 2023 | Rating: 5 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Lung Cancer Diagnostics Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
        1.2.2 Immunoassays
        1.2.3 Flow Cytometry
        1.2.4 Rapid Tests
        1.2.5 Molecular Assays
        1.2.6 Tissue Arrays
        1.2.7 Circulating Tumor Cells
        1.2.8 Pharmacodiagnostics
        1.2.9 Biomarkers
        1.2.10 Other
    1.3 Market by Application
        1.3.1 Global Lung Cancer Diagnostics Market Share by Application: 2016 VS 2021 VS 2027
        1.3.2 Industrial
        1.3.3 Healthcare
        1.3.4 Other
    1.4 Study Objectives
    1.5 Years Considered

2 Global Growth Trends
    2.1 Global Lung Cancer Diagnostics Market Perspective (2016-2027)
    2.2 Lung Cancer Diagnostics Growth Trends by Regions
        2.2.1 Lung Cancer Diagnostics Market Size by Regions: 2016 VS 2021 VS 2027
        2.2.2 Lung Cancer Diagnostics Historic Market Share by Regions (2016-2021)
        2.2.3 Lung Cancer Diagnostics Forecasted Market Size by Regions (2022-2027)
    2.3 Lung Cancer Diagnostics Industry Dynamic
        2.3.1 Lung Cancer Diagnostics Market Trends
        2.3.2 Lung Cancer Diagnostics Market Drivers
        2.3.3 Lung Cancer Diagnostics Market Challenges
        2.3.4 Lung Cancer Diagnostics Market Restraints

3 Competition Landscape by Key Players
    3.1 Global Top Lung Cancer Diagnostics Players by Revenue
        3.1.1 Global Top Lung Cancer Diagnostics Players by Revenue (2016-2021)
        3.1.2 Global Lung Cancer Diagnostics Revenue Market Share by Players (2016-2021)
    3.2 Global Lung Cancer Diagnostics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    3.3 Players Covered: Ranking by Lung Cancer Diagnostics Revenue
    3.4 Global Lung Cancer Diagnostics Market Concentration Ratio
        3.4.1 Global Lung Cancer Diagnostics Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Lung Cancer Diagnostics Revenue in 2020
    3.5 Lung Cancer Diagnostics Key Players Head office and Area Served
    3.6 Key Players Lung Cancer Diagnostics Product Solution and Service
    3.7 Date of Enter into Lung Cancer Diagnostics Market
    3.8 Mergers & Acquisitions, Expansion Plans

4 Lung Cancer Diagnostics Breakdown Data by Type
    4.1 Global Lung Cancer Diagnostics Historic Market Size by Type (2016-2021)
    4.2 Global Lung Cancer Diagnostics Forecasted Market Size by Type (2022-2027)

5 Lung Cancer Diagnostics Breakdown Data by Application
    5.1 Global Lung Cancer Diagnostics Historic Market Size by Application (2016-2021)
    5.2 Global Lung Cancer Diagnostics Forecasted Market Size by Application (2022-2027)

6 North America
    6.1 North America Lung Cancer Diagnostics Market Size (2016-2027)
    6.2 North America Lung Cancer Diagnostics Market Size by Type
        6.2.1 North America Lung Cancer Diagnostics Market Size by Type (2016-2021)
        6.2.2 North America Lung Cancer Diagnostics Market Size by Type (2022-2027)
        6.2.3 North America Lung Cancer Diagnostics Market Size by Type (2016-2027)
    6.3 North America Lung Cancer Diagnostics Market Size by Application
        6.3.1 North America Lung Cancer Diagnostics Market Size by Application (2016-2021)
        6.3.2 North America Lung Cancer Diagnostics Market Size by Application (2022-2027)
        6.3.3 North America Lung Cancer Diagnostics Market Size by Application (2016-2027)
    6.4 North America Lung Cancer Diagnostics Market Size by Country
        6.4.1 North America Lung Cancer Diagnostics Market Size by Country (2016-2021)
        6.4.2 North America Lung Cancer Diagnostics Market Size by Country (2022-2027)
        6.4.3 United States
        6.4.4 Canada

7 Europe
    7.1 Europe Lung Cancer Diagnostics Market Size (2016-2027)
    7.2 Europe Lung Cancer Diagnostics Market Size by Type
        7.2.1 Europe Lung Cancer Diagnostics Market Size by Type (2016-2021)
        7.2.2 Europe Lung Cancer Diagnostics Market Size by Type (2022-2027)
        7.2.3 Europe Lung Cancer Diagnostics Market Size by Type (2016-2027)
    7.3 Europe Lung Cancer Diagnostics Market Size by Application
        7.3.1 Europe Lung Cancer Diagnostics Market Size by Application (2016-2021)
        7.3.2 Europe Lung Cancer Diagnostics Market Size by Application (2022-2027)
        7.3.3 Europe Lung Cancer Diagnostics Market Size by Application (2016-2027)
    7.4 Europe Lung Cancer Diagnostics Market Size by Country
        7.4.1 Europe Lung Cancer Diagnostics Market Size by Country (2016-2021)
        7.4.2 Europe Lung Cancer Diagnostics Market Size by Country (2022-2027)
        7.4.3 Germany
        7.4.4 France
        7.4.5 U.K.
        7.4.6 Italy
        7.4.7 Russia
        7.4.8 Nordic

8 Asia-Pacific
    8.1 Asia-Pacific Lung Cancer Diagnostics Market Size (2016-2027)
    8.2 Asia-Pacific Lung Cancer Diagnostics Market Size by Type
        8.2.1 Asia-Pacific Lung Cancer Diagnostics Market Size by Type (2016-2021)
        8.2.2 Asia-Pacific Lung Cancer Diagnostics Market Size by Type (2022-2027)
        8.2.3 Asia-Pacific Lung Cancer Diagnostics Market Size by Type (2016-2027)
    8.3 Asia-Pacific Lung Cancer Diagnostics Market Size by Application
        8.3.1 Asia-Pacific Lung Cancer Diagnostics Market Size by Application (2016-2021)
        8.3.2 Asia-Pacific Lung Cancer Diagnostics Market Size by Application (2022-2027)
        8.3.3 Asia-Pacific Lung Cancer Diagnostics Market Size by Application (2016-2027)
    8.4 Asia-Pacific Lung Cancer Diagnostics Market Size by Region
        8.4.1 Asia-Pacific Lung Cancer Diagnostics Market Size by Region (2016-2021)
        8.4.2 Asia-Pacific Lung Cancer Diagnostics Market Size by Region (2022-2027)
        8.4.3 China
        8.4.4 Japan
        8.4.5 South Korea
        8.4.6 Southeast Asia
        8.4.7 India
        8.4.8 Australia

9 Latin America
    9.1 Latin America Lung Cancer Diagnostics Market Size (2016-2027)
    9.2 Latin America Lung Cancer Diagnostics Market Size by Type
        9.2.1 Latin America Lung Cancer Diagnostics Market Size by Type (2016-2021)
        9.2.2 Latin America Lung Cancer Diagnostics Market Size by Type (2022-2027)
        9.2.3 Latin America Lung Cancer Diagnostics Market Size by Type (2016-2027)
    9.3 Latin America Lung Cancer Diagnostics Market Size by Application
        9.3.1 Latin America Lung Cancer Diagnostics Market Size by Application (2016-2021)
        9.3.2 Latin America Lung Cancer Diagnostics Market Size by Application (2022-2027)
        9.3.3 Latin America Lung Cancer Diagnostics Market Size by Application (2016-2027)
    9.4 Latin America Lung Cancer Diagnostics Market Size by Country
        9.4.1 Latin America Lung Cancer Diagnostics Market Size by Country (2016-2021)
        9.4.2 Latin America Lung Cancer Diagnostics Market Size by Country (2022-2027)
        9.4.3 Mexico
        9.4.4 Brazil

10 Middle East & Africa
    10.1 Middle East & Africa Lung Cancer Diagnostics Market Size (2016-2027)
    10.2 Middle East & Africa Lung Cancer Diagnostics Market Size by Type
        10.2.1 Middle East & Africa Lung Cancer Diagnostics Market Size by Type (2016-2021)
        10.2.2 Middle East & Africa Lung Cancer Diagnostics Market Size by Type (2022-2027)
        10.2.3 Middle East & Africa Lung Cancer Diagnostics Market Size by Type (2016-2027)
    10.3 Middle East & Africa Lung Cancer Diagnostics Market Size by Application
        10.3.1 Middle East & Africa Lung Cancer Diagnostics Market Size by Application (2016-2021)
        10.3.2 Middle East & Africa Lung Cancer Diagnostics Market Size by Application (2022-2027)
        10.3.3 Middle East & Africa Lung Cancer Diagnostics Market Size by Application (2016-2027)
    10.4 Middle East & Africa Lung Cancer Diagnostics Market Size by Country
        10.4.1 Middle East & Africa Lung Cancer Diagnostics Market Size by Country (2016-2021)
        10.4.2 Middle East & Africa Lung Cancer Diagnostics Market Size by Country (2022-2027)
        10.4.3 Turkey
        10.4.4 Saudi Arabia
        10.4.5 UAE

11 Key Players Profiles
    11.1 Roche Diagnostics
        11.1.1 Roche Diagnostics Company Details
        11.1.2 Roche Diagnostics Business Overview
        11.1.3 Roche Diagnostics Lung Cancer Diagnostics Introduction
        11.1.4 Roche Diagnostics Revenue in Lung Cancer Diagnostics Business (2016-2021)
        11.1.5 Roche Diagnostics Recent Development
    11.2 BioMérieux
        11.2.1 BioMérieux Company Details
        11.2.2 BioMérieux Business Overview
        11.2.3 BioMérieux Lung Cancer Diagnostics Introduction
        11.2.4 BioMérieux Revenue in Lung Cancer Diagnostics Business (2016-2021)
        11.2.5 BioMérieux Recent Development
    11.3 Qiagen
        11.3.1 Qiagen Company Details
        11.3.2 Qiagen Business Overview
        11.3.3 Qiagen Lung Cancer Diagnostics Introduction
        11.3.4 Qiagen Revenue in Lung Cancer Diagnostics Business (2016-2021)
        11.3.5 Qiagen Recent Development
    11.4 Advpharma
        11.4.1 Advpharma Company Details
        11.4.2 Advpharma Business Overview
        11.4.3 Advpharma Lung Cancer Diagnostics Introduction
        11.4.4 Advpharma Revenue in Lung Cancer Diagnostics Business (2016-2021)
        11.4.5 Advpharma Recent Development
    11.5 AIT Austrian Institute of Technology
        11.5.1 AIT Austrian Institute of Technology Company Details
        11.5.2 AIT Austrian Institute of Technology Business Overview
        11.5.3 AIT Austrian Institute of Technology Lung Cancer Diagnostics Introduction
        11.5.4 AIT Austrian Institute of Technology Revenue in Lung Cancer Diagnostics Business (2016-2021)
        11.5.5 AIT Austrian Institute of Technology Recent Development
    11.6 Courtagen Life Sciences
        11.6.1 Courtagen Life Sciences Company Details
        11.6.2 Courtagen Life Sciences Business Overview
        11.6.3 Courtagen Life Sciences Lung Cancer Diagnostics Introduction
        11.6.4 Courtagen Life Sciences Revenue in Lung Cancer Diagnostics Business (2016-2021)
        11.6.5 Courtagen Life Sciences Recent Development
    11.7 DiagnoCure
        11.7.1 DiagnoCure Company Details
        11.7.2 DiagnoCure Business Overview
        11.7.3 DiagnoCure Lung Cancer Diagnostics Introduction
        11.7.4 DiagnoCure Revenue in Lung Cancer Diagnostics Business (2016-2021)
        11.7.5 DiagnoCure Recent Development
    11.8 BioMark Diagnostics
        11.8.1 BioMark Diagnostics Company Details
        11.8.2 BioMark Diagnostics Business Overview
        11.8.3 BioMark Diagnostics Lung Cancer Diagnostics Introduction
        11.8.4 BioMark Diagnostics Revenue in Lung Cancer Diagnostics Business (2016-2021)
        11.8.5 BioMark Diagnostics Recent Development
    11.9 Mayo Clinic
        11.9.1 Mayo Clinic Company Details
        11.9.2 Mayo Clinic Business Overview
        11.9.3 Mayo Clinic Lung Cancer Diagnostics Introduction
        11.9.4 Mayo Clinic Revenue in Lung Cancer Diagnostics Business (2016-2021)
        11.9.5 Mayo Clinic Recent Development
    11.10 HalioDx SAS
        11.10.1 HalioDx SAS Company Details
        11.10.2 HalioDx SAS Business Overview
        11.10.3 HalioDx SAS Lung Cancer Diagnostics Introduction
        11.10.4 HalioDx SAS Revenue in Lung Cancer Diagnostics Business (2016-2021)
        11.10.5 HalioDx SAS Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details
List of Tables
    Table 1. Global Lung Cancer Diagnostics Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
    Table 2. Key Players of Immunoassays
    Table 3. Key Players of Flow Cytometry
    Table 4. Key Players of Rapid Tests
    Table 5. Key Players of Molecular Assays
    Table 6. Key Players of Tissue Arrays
    Table 7. Key Players of Circulating Tumor Cells
    Table 8. Key Players of Pharmacodiagnostics
    Table 9. Key Players of Biomarkers
    Table 10. Key Players of Other
    Table 11. Global Lung Cancer Diagnostics Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
    Table 12. Global Lung Cancer Diagnostics Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
    Table 13. Global Lung Cancer Diagnostics Market Size by Regions (2016-2021) & (US$ Million)
    Table 14. Global Lung Cancer Diagnostics Market Share by Regions (2016-2021)
    Table 15. Global Lung Cancer Diagnostics Forecasted Market Size by Regions (2022-2027) & (US$ Million)
    Table 16. Global Lung Cancer Diagnostics Market Share by Regions (2022-2027)
    Table 17. Lung Cancer Diagnostics Market Trends
    Table 18. Lung Cancer Diagnostics Market Drivers
    Table 19. Lung Cancer Diagnostics Market Challenges
    Table 20. Lung Cancer Diagnostics Market Restraints
    Table 21. Global Lung Cancer Diagnostics Revenue by Players (2016-2021) & (US$ Million)
    Table 22. Global Lung Cancer Diagnostics Market Share by Players (2016-2021)
    Table 23. Global Top Lung Cancer Diagnostics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Lung Cancer Diagnostics as of 2020)
    Table 24. Ranking of Global Top Lung Cancer Diagnostics Companies by Revenue (US$ Million) in 2020
    Table 25. Global 5 Largest Players Market Share by Lung Cancer Diagnostics Revenue (CR5 and HHI) & (2016-2021)
    Table 26. Key Players Headquarters and Area Served
    Table 27. Key Players Lung Cancer Diagnostics Product Solution and Service
    Table 28. Date of Enter into Lung Cancer Diagnostics Market
    Table 29. Mergers & Acquisitions, Expansion Plans
    Table 30. Global Lung Cancer Diagnostics Market Size by Type (2016-2021) (US$ Million)
    Table 31. Global Lung Cancer Diagnostics Revenue Market Share by Type (2016-2021)
    Table 32. Global Lung Cancer Diagnostics Forecasted Market Size by Type (2022-2027) (US$ Million)
    Table 33. Global Lung Cancer Diagnostics Revenue Market Share by Type (2022-2027) & (US$ Million)
    Table 34. Global Lung Cancer Diagnostics Market Size Share by Application (2016-2021) & (US$ Million)
    Table 35. Global Lung Cancer Diagnostics Revenue Market Share by Application (2016-2021)
    Table 36. Global Lung Cancer Diagnostics Forecasted Market Size by Application (2022-2027) (US$ Million)
    Table 37. Global Lung Cancer Diagnostics Revenue Market Share by Application (2022-2027) & (US$ Million)
    Table 38. North America Lung Cancer Diagnostics Market Size by Type (2016-2021) (US$ Million)
    Table 39. North America Lung Cancer Diagnostics Market Size by Type (2022-2027) & (US$ Million)
    Table 40. North America Lung Cancer Diagnostics Market Size by Application (2016-2021) (US$ Million)
    Table 41. North America Lung Cancer Diagnostics Market Size by Application (2022-2027) & (US$ Million)
    Table 42. North America Lung Cancer Diagnostics Market Size by Country (2016-2021) & (US$ Million) 
    Table 43. North America Lung Cancer Diagnostics Market Size by Country (2022-2027) & (US$ Million) 
    Table 44. Europe Lung Cancer Diagnostics Market Size by Type (2016-2021) (US$ Million)
    Table 45. Europe Lung Cancer Diagnostics Market Size by Type (2022-2027) & (US$ Million)
    Table 46. Europe Lung Cancer Diagnostics Market Size by Application (2016-2021) (US$ Million)
    Table 47. Europe Lung Cancer Diagnostics Market Size by Application (2022-2027) & (US$ Million)
    Table 48. Europe Lung Cancer Diagnostics Market Size by Country (2016-2021) & (US$ Million) 
    Table 49. Europe Lung Cancer Diagnostics Market Size by Country (2022-2027) & (US$ Million) 
    Table 50. Asia-Pacific Lung Cancer Diagnostics Market Size by Type (2016-2021) (US$ Million)
    Table 51. Asia-Pacific Lung Cancer Diagnostics Market Size by Type (2022-2027) & (US$ Million)
    Table 52. Asia-Pacific Lung Cancer Diagnostics Market Size by Application (2016-2021) (US$ Million)
    Table 53. Asia-Pacific Lung Cancer Diagnostics Market Size by Application (2022-2027) & (US$ Million)
    Table 54. Asia-Pacific Lung Cancer Diagnostics Market Size by Region (2016-2021) & (US$ Million) 
    Table 55. Asia-Pacific Lung Cancer Diagnostics Market Size by Region (2022-2027) & (US$ Million) 
    Table 56. Latin America Lung Cancer Diagnostics Market Size by Type (2016-2021) (US$ Million)
    Table 57. Latin America Lung Cancer Diagnostics Market Size by Type (2022-2027) & (US$ Million)
    Table 58. Latin America Lung Cancer Diagnostics Market Size by Application (2016-2021) (US$ Million)
    Table 59. Latin America Lung Cancer Diagnostics Market Size by Application (2022-2027) & (US$ Million)
    Table 60. Latin America Lung Cancer Diagnostics Market Size by Country (2016-2021) & (US$ Million) 
    Table 61. Latin America Lung Cancer Diagnostics Market Size by Country (2022-2027) & (US$ Million) 
    Table 62. Middle East & Africa Lung Cancer Diagnostics Market Size by Type (2016-2021) (US$ Million)
    Table 63. Middle East & Africa Lung Cancer Diagnostics Market Size by Type (2022-2027) & (US$ Million)
    Table 64. Middle East & Africa Lung Cancer Diagnostics Market Size by Application (2016-2021) (US$ Million)
    Table 65. Middle East & Africa Lung Cancer Diagnostics Market Size by Application (2022-2027) & (US$ Million)
    Table 66. Middle East & Africa Lung Cancer Diagnostics Market Size by Country (2016-2021) & (US$ Million) 
    Table 67. Middle East & Africa Lung Cancer Diagnostics Market Size by Country (2022-2027) & (US$ Million) 
    Table 68. Roche Diagnostics Company Details
    Table 69. Roche Diagnostics Business Overview
    Table 70. Roche Diagnostics Lung Cancer Diagnostics Product
    Table 71. Roche Diagnostics Revenue in Lung Cancer Diagnostics Business (2016-2021) & (US$ Million)
    Table 72. Roche Diagnostics Recent Development
    Table 73. BioMérieux Company Details
    Table 74. BioMérieux Business Overview
    Table 75. BioMérieux Lung Cancer Diagnostics Product
    Table 76. BioMérieux Revenue in Lung Cancer Diagnostics Business (2016-2021) & (US$ Million)
    Table 77. BioMérieux Recent Development
    Table 78. Qiagen Company Details
    Table 79. Qiagen Business Overview
    Table 80. Qiagen Lung Cancer Diagnostics Product
    Table 81. Qiagen Revenue in Lung Cancer Diagnostics Business (2016-2021) & (US$ Million)
    Table 82. Qiagen Recent Development
    Table 83. Advpharma Company Details
    Table 84. Advpharma Business Overview
    Table 85. Advpharma Lung Cancer Diagnostics Product
    Table 86. Advpharma Revenue in Lung Cancer Diagnostics Business (2016-2021) & (US$ Million)
    Table 87. Advpharma Recent Development
    Table 88. AIT Austrian Institute of Technology Company Details
    Table 89. AIT Austrian Institute of Technology Business Overview
    Table 90. AIT Austrian Institute of Technology Lung Cancer Diagnostics Product
    Table 91. AIT Austrian Institute of Technology Revenue in Lung Cancer Diagnostics Business (2016-2021) & (US$ Million)
    Table 92. AIT Austrian Institute of Technology Recent Development
    Table 93. Courtagen Life Sciences Company Details
    Table 94. Courtagen Life Sciences Business Overview
    Table 95. Courtagen Life Sciences Lung Cancer Diagnostics Product
    Table 96. Courtagen Life Sciences Revenue in Lung Cancer Diagnostics Business (2016-2021) & (US$ Million)
    Table 97. Courtagen Life Sciences Recent Development
    Table 98. DiagnoCure Company Details
    Table 99. DiagnoCure Business Overview
    Table 100. DiagnoCure Lung Cancer Diagnostics Product
    Table 101. DiagnoCure Revenue in Lung Cancer Diagnostics Business (2016-2021) & (US$ Million)
    Table 102. DiagnoCure Recent Development
    Table 103. BioMark Diagnostics Company Details
    Table 104. BioMark Diagnostics Business Overview
    Table 105. BioMark Diagnostics Revenue in Lung Cancer Diagnostics Business (2016-2021) & (US$ Million)
    Table 106. BioMark Diagnostics Recent Development
    Table 107. Mayo Clinic Company Details
    Table 108. Mayo Clinic Business Overview
    Table 109. Mayo Clinic Lung Cancer Diagnostics Product
    Table 110. Mayo Clinic Revenue in Lung Cancer Diagnostics Business (2016-2021) & (US$ Million)
    Table 111. Mayo Clinic Recent Development
    Table 112. HalioDx SAS Company Details
    Table 113. HalioDx SAS Business Overview
    Table 114. HalioDx SAS Lung Cancer Diagnostics Product
    Table 115. HalioDx SAS Revenue in Lung Cancer Diagnostics Business (2016-2021) & (US$ Million)
    Table 116. HalioDx SAS Recent Development
    Table 117. Research Programs/Design for This Report
    Table 118. Key Data Information from Secondary Sources
    Table 119. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Lung Cancer Diagnostics Market Share by Type: 2020 VS 2027
    Figure 2. Immunoassays Features
    Figure 3. Flow Cytometry Features
    Figure 4. Rapid Tests Features
    Figure 5. Molecular Assays Features
    Figure 6. Tissue Arrays Features
    Figure 7. Circulating Tumor Cells Features
    Figure 8. Pharmacodiagnostics Features
    Figure 9. Biomarkers Features
    Figure 10. Other Features
    Figure 11. Global Lung Cancer Diagnostics Market Share by Application: 2020 VS 2027
    Figure 12. Industrial Case Studies
    Figure 13. Healthcare Case Studies
    Figure 14. Other Case Studies
    Figure 15. Lung Cancer Diagnostics Report Years Considered
    Figure 16. Global Lung Cancer Diagnostics Market Size (US$ Million), Year-over-Year: 2016-2027
    Figure 17. Global Lung Cancer Diagnostics Market Size (US$ Million), 2016 VS 2021 VS 2027
    Figure 18. Global Lung Cancer Diagnostics Market Share by Regions: 2020 VS 2027
    Figure 19. Global Lung Cancer Diagnostics Market Share by Regions (2022-2027)
    Figure 20. Global Lung Cancer Diagnostics Market Share by Players in 2020
    Figure 21. Global Top Lung Cancer Diagnostics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Lung Cancer Diagnostics as of 2020
    Figure 22. The Top 10 and 5 Players Market Share by Lung Cancer Diagnostics Revenue in 2020
    Figure 23. Global Lung Cancer Diagnostics Revenue Market Share by Type (2016-2021)
    Figure 24. Global Lung Cancer Diagnostics Revenue Market Share by Type (2022-2027)
    Figure 25. North America Lung Cancer Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 26. North America Lung Cancer Diagnostics Market Share by Type (2016-2027)
    Figure 27. North America Lung Cancer Diagnostics Market Share by Application (2016-2027)
    Figure 28. North America Lung Cancer Diagnostics Market Share by Country (2016-2027)
    Figure 29. United States Lung Cancer Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 30. Canada Lung Cancer Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 31. Europe Lung Cancer Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 32. Europe Lung Cancer Diagnostics Market Share by Type (2016-2027)
    Figure 33. Europe Lung Cancer Diagnostics Market Share by Application (2016-2027)
    Figure 34. Europe Lung Cancer Diagnostics Market Share by Country (2016-2027)
    Figure 35. Germany Lung Cancer Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 36. France Lung Cancer Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 37. U.K. Lung Cancer Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 38. Italy Lung Cancer Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 39. Russia Lung Cancer Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 40. Nordic Lung Cancer Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 41. Asia-Pacific Lung Cancer Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 42. Asia-Pacific Lung Cancer Diagnostics Market Share by Type (2016-2027)
    Figure 43. Asia-Pacific Lung Cancer Diagnostics Market Share by Application (2016-2027)
    Figure 44. Asia-Pacific Lung Cancer Diagnostics Market Share by Region (2016-2027)
    Figure 45. China Lung Cancer Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 46. Japan Lung Cancer Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 47. South Korea Lung Cancer Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 48. Southeast Asia Lung Cancer Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 49. India Lung Cancer Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 50. Australia Lung Cancer Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 51. Latin America Lung Cancer Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 52. Latin America Lung Cancer Diagnostics Market Share by Type (2016-2027)
    Figure 53. Latin America Lung Cancer Diagnostics Market Share by Application (2016-2027)
    Figure 54. Latin America Lung Cancer Diagnostics Market Share by Country (2016-2027)
    Figure 55. Mexico Lung Cancer Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 56. Brazil Lung Cancer Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 57. Middle East & Africa Lung Cancer Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 58. Middle East & Africa Lung Cancer Diagnostics Market Share by Type (2016-2027)
    Figure 59. Middle East & Africa Lung Cancer Diagnostics Market Share by Application (2016-2027)
    Figure 60. Middle East & Africa Lung Cancer Diagnostics Market Share by Country (2016-2027)
    Figure 61. Turkey Lung Cancer Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 62. Saudi Arabia Lung Cancer Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 63. UAE Lung Cancer Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 64. Roche Diagnostics Revenue Growth Rate in Lung Cancer Diagnostics Business (2016-2021)
    Figure 65. BioMérieux Revenue Growth Rate in Lung Cancer Diagnostics Business (2016-2021)
    Figure 66. Qiagen Revenue Growth Rate in Lung Cancer Diagnostics Business (2016-2021)
    Figure 67. Advpharma Revenue Growth Rate in Lung Cancer Diagnostics Business (2016-2021)
    Figure 68. AIT Austrian Institute of Technology Revenue Growth Rate in Lung Cancer Diagnostics Business (2016-2021)
    Figure 69. Courtagen Life Sciences Revenue Growth Rate in Lung Cancer Diagnostics Business (2016-2021)
    Figure 70. DiagnoCure Revenue Growth Rate in Lung Cancer Diagnostics Business (2016-2021)
    Figure 71. BioMark Diagnostics Revenue Growth Rate in Lung Cancer Diagnostics Business (2016-2021)
    Figure 72. Mayo Clinic Revenue Growth Rate in Lung Cancer Diagnostics Business (2016-2021)
    Figure 73. HalioDx SAS Revenue Growth Rate in Lung Cancer Diagnostics Business (2016-2021)
    Figure 74. Bottom-up and Top-down Approaches for This Report
    Figure 75. Data Triangulation
    Figure 76. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Roche Diagnostics
BioMérieux
Qiagen
Advpharma
AIT Austrian Institute of Technology
Courtagen Life Sciences
DiagnoCure
BioMark Diagnostics
Mayo Clinic
HalioDx SAS
Frequently Asked Questions
Lung Cancer Diagnostics report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Lung Cancer Diagnostics report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Lung Cancer Diagnostics report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Lab Accessories

Laboratory accessories support improved drug efficiency, polymerase and purification chain reacti ... Read More

Leisure Centers

A leisure centre in the UK, Ireland, Australia (also called aquatic centres) and Canada is a purp ... Read More